JP2019520801A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520801A5
JP2019520801A5 JP2018558668A JP2018558668A JP2019520801A5 JP 2019520801 A5 JP2019520801 A5 JP 2019520801A5 JP 2018558668 A JP2018558668 A JP 2018558668A JP 2018558668 A JP2018558668 A JP 2018558668A JP 2019520801 A5 JP2019520801 A5 JP 2019520801A5
Authority
JP
Japan
Prior art keywords
lactic acid
dagk
strain
bacterial strain
allergy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018558668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520801A (ja
JP7030716B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2017/050455 external-priority patent/WO2017196235A1/en
Publication of JP2019520801A publication Critical patent/JP2019520801A/ja
Publication of JP2019520801A5 publication Critical patent/JP2019520801A5/ja
Application granted granted Critical
Publication of JP7030716B2 publication Critical patent/JP7030716B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018558668A 2016-05-09 2017-05-08 アレルギー治療に有用な細菌株の選択 Active JP7030716B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1650620 2016-05-09
SE1650620-6 2016-05-09
PCT/SE2017/050455 WO2017196235A1 (en) 2016-05-09 2017-05-08 Selection of bacterial strains useful in allergy treatment

Publications (3)

Publication Number Publication Date
JP2019520801A JP2019520801A (ja) 2019-07-25
JP2019520801A5 true JP2019520801A5 (https=) 2020-06-18
JP7030716B2 JP7030716B2 (ja) 2022-03-07

Family

ID=58873850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018558668A Active JP7030716B2 (ja) 2016-05-09 2017-05-08 アレルギー治療に有用な細菌株の選択

Country Status (11)

Country Link
US (2) US11135255B2 (https=)
EP (1) EP3454874A1 (https=)
JP (1) JP7030716B2 (https=)
CN (1) CN109195612A (https=)
AU (1) AU2017262408A1 (https=)
BR (1) BR112018072511A2 (https=)
CA (1) CA3023867A1 (https=)
CL (1) CL2018003167A1 (https=)
MX (1) MX392754B (https=)
SG (1) SG11201809551TA (https=)
WO (1) WO2017196235A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4081229B1 (en) * 2019-12-24 2026-02-25 Iowa State University Research Foundation, Inc. Control of histamine to increase feeding efficiency and treat or prevent preventing and/or treating clostridial dermatitis and/or clostridial enteric disease using brevibacterium aureum, brevibacterium sediminis, and/or brevibacterium epidermidis
JP7515153B2 (ja) * 2020-03-06 2024-07-12 学校法人麻布獣医学園 乳酸菌含有組成物
CN113073066B (zh) * 2021-04-16 2022-01-04 段云峰 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN114317326B (zh) * 2021-12-06 2023-09-12 浙江工商大学 一种用于缓解过敏反应的清酒乳杆菌及制备方法
CN115025130A (zh) * 2022-06-02 2022-09-09 广东南芯医疗科技有限公司 罗伊氏乳杆菌e9在制备治疗或预防过敏性疾病药物中的应用
CN116376758B (zh) * 2023-03-15 2024-07-02 广东南芯医疗科技有限公司 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
KR100507417B1 (ko) 2003-01-27 2005-08-10 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를 함유한 항알레르기 제품
AU2005303893A1 (en) 2004-11-11 2006-05-18 Argenta Discovery Ltd Pyrimidine compounds as histamine modulators
US8017592B2 (en) * 2006-04-13 2011-09-13 Alcon Research, Ltd. RNAi-mediated inhibition of histamine receptor H1-related conditions
JP2008127365A (ja) 2006-11-24 2008-06-05 Kowa Co アレルギー性疾患の予防及び/又は治療剤
US20110217290A1 (en) * 2008-08-18 2011-09-08 Manel Jordana Treatment and/or prevention of peanut induced anaphylaxis
JP2011254773A (ja) 2010-06-11 2011-12-22 Bio Plan:Kk 乳酸菌の菌株及びこれを利用したアレルギー抑制剤
WO2012012390A1 (en) * 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
WO2014130759A1 (en) * 2013-02-21 2014-08-28 University Of Rochester Methods of using histamine receptor agonists and antagonists
JP6195268B2 (ja) 2013-07-18 2017-09-13 国立大学法人徳島大学 鼻炎の予防治療装置
MX2017012359A (es) * 2015-03-26 2018-07-06 Biogaia Ab Cepas bacterianas productoras de histamina y su uso en cancer.

Similar Documents

Publication Publication Date Title
JP2019520801A5 (https=)
Bourrie et al. The microbiota and health promoting characteristics of the fermented beverage kefir
Martens et al. Probiotics for the airways: potential to improve epithelial and immune homeostasis
Ou et al. Heat‐killed lactic acid bacteria enhance immunomodulatory potential by skewing the immune response toward Th1 polarization
Rather et al. Probiotics and atopic dermatitis: an overview
Mishra et al. A brief overview on probiotics: the health friendly microbes
Sharma et al. Antibiotic resistance among commercially available probiotics
Wu et al. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation
Hidalgo-Cantabrana et al. Exopolysaccharide-producing Bifidobacterium animalis subsp. lactis strains and their polymers elicit different responses on immune cells from blood and gut associated lymphoid tissue
Jonganurakkun et al. Pediococcus pentosaceus NB-17 for probiotic use
Prajapati et al. Advances in probiotics research: mechanisms of action, health benefits, and limitations in applications
RU2018113245A (ru) Новая лактобактерия, характеризующаяся различными функциями, и ее применение
JP2015213501A5 (https=)
RU2014107770A (ru) Композиция, содержащая n-ацетилцистеин и/или микроинкапсулированный защищенный от действия желудочного сока лизоцим в сочетании с пробиотическими бактериями, способная восстанавливать собственный барьерный эффект желудка, который утрачивается во время фармалогического лечения желудочной гиперацидности
MY146595A (en) Probiotic bifidobacterium strains
MX349706B (es) Bifidobacterium longum.
Helmy et al. In vitro evaluation of the impact of the probiotic E. coli Nissle 1917 on Campylobacter jejuni’s invasion and intracellular survival in human colonic cells
Kitazawa et al. Probiotics: immunobiotics and immunogenics
Eom et al. Protective effects of a novel probiotic strain of Lactobacillus plantarum JSA22 from traditional fermented soybean food against infection by Salmonella enterica serovar Typhimurium
US11969445B2 (en) Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
MX383749B (es) Cepas probioticas con capacidad de absorber colesterol, métodos y usos de las mismas
HK1198326A1 (zh) 用於预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种
JP2006273852A5 (https=)
JP2016065039A5 (https=)
CN105555283A (zh) 用于婴儿过度啼哭的益生菌